Mersana Therapeutics, Inc. Operating Cash Flow
Mersana Therapeutics, Inc. reported Operating Cash Flow of -$55.12 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2025-11-14
- Mersana Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$3.19M.
- Mersana Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-06-30 was -$22.60M.
- Mersana Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-03-31 was -$29.33M.
- Mersana Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2024-12-31 was -$19.25M.
- Mersana Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$82.34M.
- Mersana Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$168.88M.
- Mersana Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$49.36M.
- Mersana Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$139.99M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$3.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$25.79M derived: sum of 2 quarters · filed 2025-11-14 | -$55.12M 10-Q · filed 2025-11-14 | -$74.37M derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-06-30 | -$22.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$51.93M 10-Q · filed 2025-08-13 | -$71.18M derived: sum of 3 quarters · filed 2025-08-13 | -$79.76M derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-03-31 | -$29.33M 10-Q · filed 2025-05-15 | -$48.58M derived: sum of 2 quarters · filed 2025-05-15 | -$57.15M derived: sum of 3 quarters · filed 2025-11-14 | -$79.01M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-12-31 | -$19.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$27.83M derived: sum of 2 quarters · filed 2025-11-14 | -$49.68M derived: sum of 3 quarters · filed 2025-11-14 | -$82.34M 10-K · filed 2025-03-03 |
| 2024-09-30 | -$8.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$30.43M derived: sum of 2 quarters · filed 2025-11-14 | -$63.09M 10-Q · filed 2025-11-14 | -$95.05M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$21.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$54.51M 10-Q · filed 2025-08-13 | -$86.47M derived: sum of 3 quarters · filed 2025-08-13 | -$132.56M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | -$32.66M 10-Q · filed 2025-05-15 | -$64.62M derived: sum of 2 quarters · filed 2025-05-15 | -$110.70M derived: sum of 3 quarters · filed 2025-05-15 | -$172.53M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$31.96M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$78.04M derived: sum of 2 quarters · filed 2025-03-03 | -$139.88M derived: sum of 3 quarters · filed 2025-03-03 | -$168.88M 10-K · filed 2025-03-03 |
| 2023-09-30 | -$46.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$107.92M derived: sum of 2 quarters · filed 2024-11-13 | -$136.92M 10-Q · filed 2024-11-13 | -$188.15M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | -$61.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$90.84M 10-Q · filed 2024-08-13 | -$142.07M derived: sum of 3 quarters · filed 2025-03-03 | -$87.47M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | -$29.00M 10-Q · filed 2024-05-09 | -$80.23M derived: sum of 2 quarters · filed 2025-03-03 | -$25.64M derived: sum of 3 quarters · filed 2025-03-03 | -$70.41M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | -$51.23M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $3.37M derived: sum of 2 quarters · filed 2025-03-03 | -$41.41M derived: sum of 3 quarters · filed 2025-03-03 | -$49.36M 10-K · filed 2025-03-03 |
| 2022-09-30 | $54.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $9.82M derived: sum of 2 quarters · filed 2023-11-07 | $1.87M 10-Q · filed 2023-11-07 | -$40.53M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$44.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$52.73M 10-Q · filed 2023-08-08 | -$95.13M derived: sum of 3 quarters · filed 2024-02-28 | -$131.23M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$7.96M 10-Q · filed 2023-05-09 | -$50.35M derived: sum of 2 quarters · filed 2024-02-28 | -$86.45M derived: sum of 3 quarters · filed 2024-02-28 | -$120.92M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$42.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$78.50M derived: sum of 2 quarters · filed 2024-02-28 | -$112.97M derived: sum of 3 quarters · filed 2024-02-28 | -$139.99M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$36.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$70.57M derived: sum of 2 quarters · filed 2022-11-07 | -$97.59M 10-Q · filed 2022-11-07 | -$114.91M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$34.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$61.49M 10-Q · filed 2022-08-08 | -$78.81M derived: sum of 3 quarters · filed 2023-02-28 | -$99.00M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$27.02M 10-Q · filed 2022-05-09 | -$44.34M derived: sum of 2 quarters · filed 2023-02-28 | -$64.54M derived: sum of 3 quarters · filed 2023-02-28 | -$80.47M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$17.32M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$37.52M derived: sum of 2 quarters · filed 2023-02-28 | -$53.45M derived: sum of 3 quarters · filed 2023-02-28 | -$74.70M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$20.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$36.13M derived: sum of 2 quarters · filed 2021-11-09 | -$57.38M 10-Q · filed 2021-11-09 | -$69.95M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | -$15.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | -$37.18M 10-Q · filed 2021-08-06 | -$49.76M derived: sum of 3 quarters · filed 2022-02-28 | -$66.04M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | -$21.25M 10-Q · filed 2021-05-10 | -$33.82M derived: sum of 2 quarters · filed 2022-02-28 | -$50.11M derived: sum of 3 quarters · filed 2022-02-28 | -$64.30M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$12.58M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$28.86M derived: sum of 2 quarters · filed 2022-02-28 | -$43.06M derived: sum of 3 quarters · filed 2022-02-28 | -$67.74M 10-K · filed 2022-02-28 |
| 2019-09-30 | -$16.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$30.48M derived: sum of 2 quarters · filed 2020-11-09 | -$55.17M 10-Q · filed 2020-11-09 | -$71.07M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | -$14.20M 10-Q · filed 2019-08-08 | -$38.88M 10-Q · filed 2020-08-07 | -$54.79M derived: sum of 3 quarters · filed 2021-02-26 | -$65.26M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | -$24.69M 10-Q · filed 2020-05-08 | -$40.59M derived: sum of 2 quarters · filed 2021-02-26 | -$51.06M derived: sum of 3 quarters · filed 2021-02-26 | -$62.51M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | -$15.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$26.38M derived: sum of 2 quarters · filed 2021-02-26 | -$37.83M derived: sum of 3 quarters · filed 2021-02-26 | -$55.22M 10-K · filed 2021-02-26 |
| 2018-09-30 | -$10.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$21.92M derived: sum of 2 quarters · filed 2019-11-06 | -$39.31M 10-Q · filed 2019-11-06 | -$50.31M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | -$11.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$28.84M 10-Q · filed 2019-08-08 | -$39.83M derived: sum of 3 quarters · filed 2020-02-28 | -$50.92M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | -$17.39M 10-Q · filed 2019-05-09 | -$28.39M derived: sum of 2 quarters · filed 2020-02-28 | -$39.47M derived: sum of 3 quarters · filed 2020-02-28 | -$49.16M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | -$11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$22.08M derived: sum of 2 quarters · filed 2020-02-28 | -$31.77M derived: sum of 3 quarters · filed 2020-02-28 | -$42.68M 10-K · filed 2020-02-28 |
| 2017-09-30 | -$11.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | -$20.77M derived: sum of 2 quarters · filed 2018-11-13 | -$31.68M 10-Q · filed 2018-11-13 | -$18.51M derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-06-30 | -$9.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$20.60M 10-Q · filed 2018-08-14 | -$7.42M derived: sum of 3 quarters · filed 2019-03-08 | -$12.20M derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-03-31 | -$10.91M 10-Q · filed 2018-05-15 | $2.27M derived: sum of 2 quarters · filed 2019-03-08 | -$2.51M derived: sum of 3 quarters · filed 2019-03-08 | |
| 2016-12-31 | $13.18M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $8.40M derived: sum of 2 quarters · filed 2019-03-08 | $31.59M 10-K · filed 2019-03-08 | |
| 2016-09-30 | -$4.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $18.41M 10-Q · filed 2017-11-13 | ||
| 2016-06-30 | $23.19M 10-Q · filed 2017-08-11 | |||
| 2015-12-31 | -$9.64M 10-K · filed 2018-03-28 |